Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
0(0%)
Results Posted
80%(4 trials)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_2
2
25%
Ph early_phase_1
1
13%
Ph phase_1
1
13%
Ph phase_4
2
25%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Terminated(3)

Detailed Status

Completed5
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
71.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 42 (28.6%)
N/A1 (14.3%)

Trials by Status

completed563%
terminated225%
withdrawn113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

NCT01391962
completedphase_2

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

NCT04865731
terminatednot_applicable

StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis

NCT05553392
completedphase_4

Steroid-reducing Effects of Crisaborole

NCT03832010
completed

Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis

NCT05810194
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT01391962Phase 2

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Completed
NCT04865731Phase 2

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

Completed
NCT05553392Not Applicable

StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis

Terminated
NCT03832010Phase 4

Steroid-reducing Effects of Crisaborole

Completed
NCT05810194

Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis

Completed
NCT02534129Phase 1

Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

Terminated
NCT01135290Early Phase 1

Post Treatment Care After Chemical Peel or Laser Resurfacing

Withdrawn
NCT00162747Phase 4

Topical Therapy for Prevention of Infections in Preterm Infants

Completed

All 8 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
8